Skip to main content

Table 1 Baseline characteristics of patients before and after the stabilised IPTW using propensity scores

From: Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study

Characteristics All patients Patients after IPTW estimation
mPSL alone group (n = 2602) % rTM group (n = 212) % SMD mPSL alone group (n = 2611) % rTM group (n = 190) % SMD
Male sex 1962 75.4 159 75 − 0.9 1971 75.5 137 72.1 − 7.6
Age, years
 15–70 640 24.6 64 30.2 12.6 655 25.1 54 28.4 8.2
 71–80 1147 44.1 104 49.1 10 1159 44.4 91 47.9 6.7
 ≥ 80 805 30.9 43 20.3 − 24.6 787 30.1 43 22.6 − 17.2
 Missing data 10 0.4 1 0.5 1.3 10 0.4 2 1.1 7.3
Treatment year
 2014 546 21 38 17.9 − 7.7 541 20.7 36 18.9 − 4.6
 2015 566 21.8 60 28.3 15.2 583 22.3 41 21.6 − 1.7
 2016 531 20.4 43 20.3 − 0.3 532 20.4 41 21.6 3.7
 2017 472 18.1 42 19.8 4.3 475 18.2 29 15.3 − 7.6
 2018 487 18.7 29 13.7 − 13.7 482 18.5 42 22.1 9.7
BMI (kg/m2)
 < 23 1282 49.3 105 49.5 0.5 1288 49.3 102 53.7 9.1
 23–25 507 19.5 35 16.5 − 7.8 500 19.1 29 15.3 − 10.2
 ≥ 25 555 21.3 52 24.5 7.6 567 21.7 43 22.6 1.9
 Missing data 258 9.9 20 9.4 − 1.6 257 9.8 16 8.4 − 5.2
Hugh–Jones dyspnoea score upon admission
 1–2 205 7.9 15 7.1 − 3.1 202 7.7 13 6.8 − 3.2
 3 168 6.5 8 3.8 − 12.2 163 6.2 11 5.8 − 2.7
 4 329 12.6 23 10.8 − 5.6 324 12.4 18 9.5 − 9.7
 5 1177 45.2 69 32.5 − 26.2 1154 44.2 85 44.7 0.7
 Missing data 723 27.8 97 45.8 37.9 767 29.4 64 33.7 9
Japan Coma Scale score upon admission
 0- or 1-digit (alert or dull) 2460 94.5 195 92 − 10.2 2463 94.3 180 94.7 2.7
 2-digit (somnolence) 73 2.8 9 4.2 7.8 77 2.9 4 2.1 − 3.8
 3-digit (coma) 69 2.7 8 3.8 6.4 72 2.8 5 2.6 0
Charlson Comorbidity Index
 0 545 20.9 45 21.2 0.7 544 20.8 39 20.5 − 0.2
 1 357 13.7 27 12.7 − 2.9 358 13.7 28 14.7 2.7
 2 510 19.6 34 16 − 9.3 504 19.3 32 16.8 − 5.7
 ≥ 3 303 11.6 21 9.9 − 5.6 302 11.6 20 10.5 − 3.0
Missing data 887 34.1 85 40.1 12.5 904 34.6 70 36.8 4.7
Smoking index, pack-years
 0 1113 42.8 79 37.3 − 11.3 1104 42.3 81 42.6 0.5
 1–39 546 21 50 23.6 6.3 553 21.2 37 19.5 − 4.8
 ≥ 40 618 23.8 51 24.1 0.7 618 23.7 37 19.5 − 10.8
 Missing data 325 12.5 32 15.1 7.6 337 12.9 36 18.9 16.7
ADL upon admission (Barthel Index)
 100 519 19.9 53 25 12.1 526 20.1 33 17.4 − 6.6
 ≤ 95 1612 62 118 55.7 − 12.8 1607 61.5 120 63.2 3.7
 Missing data 471 18.1 41 19.3 3.2 479 18.3 36 18.9 2.0
History of previous hospitalisation
 0 1457 56 110 51.9 − 8.2 1455 55.7 108 56.8 2.4
 1–2 792 30.4 78 36.8 13.5 807 30.9 57 30.0 − 1.9
 ≥ 3 353 13.6 24 11.3 − 6.8 350 13.4 25 13.2 − 0.9
 Academic hospital 2169 83.4 179 84.4 2.9 2179 83.5 164 86.3 7.6
 ICU admission 665 25.6 68 32.1 14.4 683 26.2 55 28.9 6.3
  1. Data were presented as n (%)
  2. BMI body mass index, ADL activities of daily living, ICU intensive care unit, IPTW inverse probability of treatment weighting, mPSL methylprednisolone, rTM recombinant human soluble thrombomodulin, SMD standardised mean difference
Back to article page

Journal of Intensive Care

ISSN: 2052-0492